BCR | Distant metastasis | ||||||||
---|---|---|---|---|---|---|---|---|---|
Univariate | Multivariate | Univariate | Multivariate | ||||||
p-value | HR | 95% CI | p-value | p-value | HR | 95% CI | p-value | ||
Age (years) | 0.001* | 1.001 | 0.990–1.012 | 0.855 | 0.048* | 1.023 | 0.992–1.055 | 0.149 | |
Initial PSA (ng/mL) | ≥20 | <0.001* | 2.230 | 1.867–2.662 | <0.001* | <0.001* | 1.495 | 0.950–2.353 | 0.082 |
Pathologic T stage | |||||||||
3 | <0.001* | 1.522 | 1.253–1.849 | <0.001* | 0.103 | 0.704 | 0.409–1.212 | 0.205 | |
4 | <0.001* | 1.707 | 1.094–2.664 | 0.019* | <0.001* | 2.399 | 1.026–5.611 | 0.043* | |
Pathologic Gleason score | |||||||||
7 | <0.001* | 1.953 | 1.521–2.508 | <0.001* | <0.001* | 1.123 | 0.566–2.229 | 0.741 | |
≥8 | <0.001* | 3.233 | 2.474–4.224 | <0.001* | <0.001* | 3.284 | 1.670–6.454 | 0.001* | |
PSM | <0.001* | 2.125 | 1.775–2.543 | <0.001* | 0.005* | 1.317 | 0.819–2.118 | 0.256 | |
LVI | <0.001* | 1.352 | 1.045–1.749 | 0.022* | <0.001* | 1.738 | 1.024–2.950 | 0.040* | |
Lymph node metastasis | <0.001* | 1.459 | 1.035–2.056 | 0.031* | <0.001* | 5.083 | 2.954–8.749 | <0.001* |